Article
Agreement between two real-time commercial PCR kits and an in-house real-time PCR for diagnosis of mucormycosis
25 Jun 2024
Abstract excerpt
ABSTRACT Mucormycosis is a severe and emerging invasive fungal infection associated with high mortality rates. Early diagnosis is crucial for initiating specific antifungal treatment, with molecular tools currently representing the most efficient diagnostic approach. Presently, a standardized in-house real-time PCR method is widely employed for diagnosing mucormycosis. Our study aimed to evaluate the agreement...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
